These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16477482)

  • 1. Botulinum toxin in patients with multiple sclerosis.
    Kabus C; Hecht M; Japp G; Jost WH; Pöhlau D; Stuckrad-Barre S; Winterholler M
    J Neurol; 2006 Feb; 253 Suppl 1():I26-8. PubMed ID: 16477482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
    Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the pendulum test: application to multiple sclerosis patients treated with botulinum toxin.
    Bianchi L; Monaldi F; Paolucci S; Iani C; Lacquaniti F
    Funct Neurol; 1999; 14(2):79-92. PubMed ID: 10399620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The place of the botulinum toxin in the management of multiple sclerosis.
    Habek M; Karni A; Balash Y; Gurevich T
    Clin Neurol Neurosurg; 2010 Sep; 112(7):592-6. PubMed ID: 20615606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin- an effective treatment for acquired nystagmus with oscillopsia.
    Menon GJ; Thaller VT
    Eye (Lond); 2002 Nov; 16(6):804-6. PubMed ID: 12439689
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles.
    Thomson AJ; Jarvis SK; Lenart M; Abbott JA; Vancaillie TG
    BJOG; 2005 Feb; 112(2):247-9. PubMed ID: 15663593
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
    Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
    BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey-Hailey disease.
    Koeyers WJ; Van Der Geer S; Krekels G
    J Dermatolog Treat; 2008; 19(4):251-4. PubMed ID: 18629693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A for the treatment of chronic anal fissure.
    Brisinda G; Cadeddu F; Mazzeo P; Maria G
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):219-28. PubMed ID: 19072412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence spasm treated with botulinum toxin.
    Kaczmarek BB; Dawson E; Lee JP
    Strabismus; 2009; 17(1):49-51. PubMed ID: 19301195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cutaneous uses for botulinum toxin type A.
    Bansal C; Omlin KJ; Hayes CM; Rohrer TE
    J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of botulinum toxin in the management of head and neck cancer patients.
    Laskawi R; Ellies M
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):112-6. PubMed ID: 17413413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia].
    Ruiz Huete C; Bermejo P
    Neurologia; 2008 May; 23(4):259-62. PubMed ID: 18516748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spasticity and multiple sclerosis].
    Bussel B; Neris OR; Mailhan L
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1041-4. PubMed ID: 11787334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.